News & Stories Health Care Production of cheaper alternatives to name brand obesity drugs will stop on Wednesday Sydney Lupkin March 18, 2025 / 2:29 pm Large-scale compounding facilities have to stop making tirzepatide, the main ingredient in blockbuster obesity drug Zepbound, Wednesday. Why you can trust KUOW Recommended Stories After loss of tax credits, WA sees a drop in insurance coverage February 09, 2026 Thousands of Washington state Medicare users could soon have claims denied by AI December 01, 2025 WA fines Regence Blue Shield $550K over shortfalls with mental health coverage November 25, 2025
